The efficacy of betulinic acid in triple-negative breast cancer

PURPOSE: The treatment of triple-negative breast cancer remains a daunting challenge with the standard-of-care treatments eventually failing due to acquired drug resistance, toxic side effects and the presence of a deregulated immune response. New treatments for overcoming these drawbacks include th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:SAGE Open Med
Autors principals: Weber, Daniel, Zhang, Mixia, Zhuang, Pengwei, Zhang, Yanjun, Wheat, Janelle, Currie, Geoffrey, Al-Eisawi, Zaynab
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2014
Matèries:
Original Manuscript
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607226/
https://ncbi.nlm.nih.gov/pubmed/26770742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312114551974
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars